TAYLOR BEAVERS: Open Payments
NPI 1669194510 · SALEM, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,740 in 133 payments from 20 companies in 2025. Trend: 2023 $2,871 · 2024 $2,883 · 2025 $2,740
Food & beverage: $2,453Education: $287
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 15 | $432 |
| ABBVIE INC. | 20 | $308 |
| Amgen Inc. | 12 | $286 |
| UCB, Inc. | 10 | $251 |
| GENZYME CORPORATION | 16 | $242 |
| Novartis Pharmaceuticals Corporation | 23 | $242 |
| Organon LLC | 5 | $205 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 10 | $193 |
| Mallinckrodt Hospital Products Inc. | 4 | $99 |
| SANOFI-AVENTIS U.S. LLC | 1 | $97 |
Products named: TREMFYA, DUPIXENT, OTEZLA, Bimzelx, SKYRIZI, COSENTYX, VTAMA, ACTHAR.
Industry payments across OR — which companies pay providers there.
